Back
BioCryst Pharmaceuticals, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
59
BCRX
BioCryst Pharmaceuticals, Inc.
Last Price:
$9.03
Seasonality Move:
15.89%
7 Day Trial
ALL ACCESS PASS
$
7
BioCryst Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, BioCryst Pharmaceuticals, Inc. has on average historically risen by 66.1% based on the past 32 years of stock performance.
-
BioCryst Pharmaceuticals, Inc. has risen higher in 15 of those 32 years over the subsequent 52-week period, corresponding to a historical accuracy of 46.88%
-
Is BioCryst Pharmaceuticals, Inc. Stock Undervalued?The current BioCryst Pharmaceuticals, Inc. [BCRX] share price is $9.02. The Score for BCRX is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
BCRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will BioCryst Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, BioCryst Pharmaceuticals, Inc. has on average historically risen by 66.1% based on the past 32 years of stock performance.
BioCryst Pharmaceuticals, Inc. Stock Rating
Buy
59
BioCryst Pharmaceuticals, Inc. (BCRX)
is a Buy
Is BioCryst Pharmaceuticals, Inc. overpriced?
-
BioCryst Pharmaceuticals, Inc. has risen higher in 15 of those 32 years over the subsequent 52-week period, corresponding to a historical accuracy of 46.88%
BioCryst Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biocryst.com
52-Week Data
52-Week High:
11.31
52-Week Low:
6.00
Prediction Charts
Market Cap:
2.2B
Price in USD:
9.02
Volume:
7.8M
Beta:
1.64
Technical Analysis
SMA50:
7.98
SMA100:
7.64
SMA200:
7.88
52-Wk Change:
21.4%
Stock Predictions
-
Is BioCryst Pharmaceuticals, Inc. stock public?Yes, BioCryst Pharmaceuticals, Inc. is a publicly traded company.
-
What is the BioCryst Pharmaceuticals, Inc. stock quote today?The BioCryst Pharmaceuticals, Inc. stock price is 9.02 USD today.
-
How to buy BioCryst Pharmaceuticals, Inc. stock online?You can buy BioCryst Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-16 | 8.22 | 9.30 | 9.60 | 8.20 |
| Mar-17 | 9.30 | 9.21 | 9.57 | 8.95 |
| Mar-18 | 9.18 | 9.16 | 9.19 | 8.91 |
| Mar-19 | 9.15 | 9.81 | 9.98 | 9.05 |
| Mar-20 | 9.73 | 9.70 | 10.32 | 9.64 |
| Mar-23 | 9.83 | 9.80 | 10.04 | 9.63 |
| Mar-24 | 10.13 | 9.66 | 10.13 | 9.42 |
| Mar-25 | 9.90 | 9.40 | 10.11 | 9.25 |
| Mar-26 | 9.19 | 9.56 | 9.69 | 8.89 |
| Mar-27 | 9.59 | 9.33 | 9.73 | 9.33 |
| Mar-30 | 9.28 | 9.45 | 9.52 | 9.17 |
| Mar-31 | 9.57 | 9.52 | 9.69 | 9.30 |
| Apr-1 | 9.54 | 9.38 | 9.66 | 9.27 |
| Apr-2 | 9.31 | 9.02 | 9.35 | 8.92 |
BioCryst Pharmaceuticals, Inc. Earnings
BioCryst Pharmaceuticals, Inc. Earnings Report: Per Share BioCryst Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
BioCryst Pharmaceuticals, Inc. Forecast Revenue Growth
BioCryst Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for BioCryst Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $0.32 per share.
* BioCryst Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.